Log in
Enquire now
‌

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Patent 11999955 was granted and assigned to Avidity Biosciences on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Avidity Biosciences
Avidity Biosciences
0
Date Filed
November 4, 2022
0
Date of Patent
June 4, 2024
0
Patent Applicant
Avidity Biosciences
Avidity Biosciences
0
Patent Application Number
18052898
0
Patent Citations
‌
US Patent 7067511 Pyrrolobenzodiazepines
0
‌
US Patent 7078196 RNA interference mediating small RNA molecules
0
‌
US Patent 7132519 Releasable nonvolatile mass-label molecules
0
‌
US Patent 7244724 Pyrrolobenzodiazepines
0
‌
US Patent 7250496 Bioinformatically detectable group of novel regulatory genes and uses thereof
0
‌
US Patent 7276497 Cytotoxic agents comprising new maytansinoids
0
‌
US Patent 7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereof
0
‌
US Patent 7364731 Polypeptide variants
0
‌
US Patent 7432249 Oligoribonucleotides and ribonucleases for cleaving RNA
0
‌
US Patent 7432250 Oligoribonucleotides and ribonucleases for cleaving RNA
0
•••
Patent Inventor Names
Rob Burke
0
David Sala Cano
0
Beatrice Diana Darimont
0
Barbora Malecova
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11999955
0
Patent Primary Examiner
‌
Aurora M Fontainhas
0

Find more entities like US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.